Michael E. Hurlston - 04 Jun 2026 Form 4 Insider Report for Astera Labs, Inc. (ALAB)

Reporting relationship: Director
Issuer ticker: ALAB
Reported as of: 04 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jun 2026, 20:23:21 UTC
Prior SEC filing: 19 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Philip Mazzara, Attorney-in-Fact

Key filing fact

Michael E. Hurlston filed Form 4 for Astera Labs, Inc. (ALAB) on 08 Jun 2026.

Key facts

This page summarizes Michael E. Hurlston's Form 4 filing for Astera Labs, Inc. (ALAB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Jun 2026, 20:23.

Change

Previous filing in this sequence was filed on 19 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001573338 Primary reporting owner

HURLSTON MICHAEL E.

Relationship: Director
Address: C/O ASTERA LABS, INC., 2345 NORTH FIRST STREET, SAN JOSE
Signature: /s/ Philip Mazzara, Attorney-in-Fact
Signature date: 08 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALAB transaction

Common Stock

Award

Transaction value
Shares: +837
Change %: +0.91%
Price: $0.000000^*
Shares after: 92,482
Date: 04 Jun 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares represent an award of restricted stock units ("RSUs") granted on June 4, 2026 (the "Grant Date") under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award vests in full upon the earlier of (i) the first anniversary of the Grant Date or (ii) the date of the next annual stockholder meeting of the Company following the Grant Date, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F2

Includes deferred stock units and dividend equivalent units.